Onderneming Rekah Pharmaceutical Industry Ltd. TEL AVIV STOCK EXCHANGE
Aandelen
IL0010810096
Farmaceutische producten
Vakgebied
Verkoop per activiteit
ILS in miljoen | 2021 | Gewicht | 2022 | Gewicht | Delta |
---|---|---|---|---|---|
Core Products
64,8
%
| 161 | 60,9 % | 190 | 64,8 % | +17,90% |
Distribution Special
29,8
%
| 88 | 33,5 % | 87 | 29,8 % | -1,33% |
Other
5,4
%
| 15 | 5,6 % | 16 | 5,4 % | +5,64% |
Verkoop per regio
ILS in miljoen | 2021 | Gewicht | 2022 | Gewicht | Delta |
---|---|---|---|---|---|
Israel
100,0
%
| 264 | 100,0 % | 292 | 100,0 % | +10,78% |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Chief Executive Officer | 80 | 24-08-93 | |
Yuval Bernshtein
DFI | Director of Finance/CFO | 44 | 01-11-18 |
Director/Board Member | 78 | 24-08-93 | |
Jack Azran
PRN | Corporate Officer/Principal | - | - |
Guy Zangi
SAM | Sales & Marketing | 51 | 13-09-18 |
Yuval Elgrably
PRN | Corporate Officer/Principal | 47 | 31-03-11 |
Ronit Zelnik
PRN | Corporate Officer/Principal | 66 | 09-01-97 |
Joseph Ginossar
AUD | Comptroller/Controller/Auditor | 65 | 15-06-14 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Ishay Davidi
BRD | Director/Board Member | 62 | 15-04-15 |
Amiram Boehm
BRD | Director/Board Member | 52 | 15-04-15 |
Avraham Bigger
CHM | Chairman | 77 | 15-04-15 |
Chief Executive Officer | 80 | 24-08-93 | |
Director/Board Member | 78 | 24-08-93 | |
Orly Silberman
BRD | Director/Board Member | 64 | 15-04-15 |
Udi Nissan Nisan
BRD | Director/Board Member | 55 | 01-11-16 |
Arnon Zuaretz
BRD | Director/Board Member | 70 | 01-11-16 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 11 523 922 | 2 000 627 ( 17,36 %) | 19 900 ( 0,1727 %) | 17,36 % |
Bedrijfsgegevens
Sector
Verkoop per activiteit
Vaira. 1 jan. | Kapi. | |
---|---|---|
+21,93% | 73,38 mld. | |
-1,71% | 24,13 mld. | |
+7,58% | 8,78 mld. | |
+10,34% | 8,59 mld. | |
-19,80% | 8,06 mld. | |
+14,16% | 5,26 mld. | |
-0,03% | 4,21 mld. | |
+12,70% | 4,17 mld. | |
-2,54% | 3,89 mld. |